Literature DB >> 9203930

Hepatitis B virus infection and liver transplantation.

N A Terrault1, T L Wright.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9203930      PMCID： PMC1027154          DOI： 10.1136/gut.40.5.568

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  41 in total

1.  Recurrent HBV/HDV infections under different immunoprophylaxis protocols.

Authors:  P Rimoldi; L S Belli; G F Rondinara; A Alberti; L DeCarlis; E Minola; V Pirotta; A Meroni; F Romani; V Sansalone
Journal:  Transplant Proc       Date:  1993-08       Impact factor: 1.066

2.  In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus.

Authors:  T Shaw; P Amor; G Civitico; M Boyd; S Locarnini
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

3.  Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis.

Authors:  D K Wong; A M Cheung; K O'Rourke; C D Naylor; A S Detsky; J Heathcote
Journal:  Ann Intern Med       Date:  1993-08-15       Impact factor: 25.391

4.  Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease.

Authors:  P Marcellin; D Samuel; J Areias; M A Loriot; J L Arulnaden; M Gigou; M F David; A Bismuth; M Reynes; C Bréchot
Journal:  Hepatology       Date:  1994-01       Impact factor: 17.425

5.  Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation.

Authors:  V König; U Hopf; P Neuhaus; J Bauditz; C A Schmidt; G Blumhardt; W O Bechstein; R Neuhaus; H Lobeck
Journal:  Transplantation       Date:  1994-09-15       Impact factor: 4.939

6.  Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant.

Authors:  J W Fang; F Y Tung; G L Davis; D J Dolson; D H Van Thiel; J Y Lau
Journal:  Gastroenterology       Date:  1993-09       Impact factor: 22.682

7.  Retransplantation in hepatitis B--a multicenter experience.

Authors:  J Crippin; B Foster; S Carlen; A Borcich; H Bodenheimer
Journal:  Transplantation       Date:  1994-03-27       Impact factor: 4.939

8.  Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation.

Authors:  K G Benner; R G Lee; E B Keeffe; R R Lopez; A W Sasaki; C W Pinson
Journal:  Gastroenterology       Date:  1992-10       Impact factor: 22.682

9.  Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients.

Authors:  H I Wright; J S Gavaler; D H Van Theil
Journal:  Transplantation       Date:  1992-01       Impact factor: 4.939

10.  Liver transplantation in European patients with the hepatitis B surface antigen.

Authors:  D Samuel; R Muller; G Alexander; L Fassati; B Ducot; J P Benhamou; H Bismuth
Journal:  N Engl J Med       Date:  1993-12-16       Impact factor: 91.245
View more
  2 in total

Review 1.  Recent advances in prevention of hepatitis B recurrence after liver transplantation.

Authors:  Zhi-Feng Xi; Qiang Xia
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

Review 2.  Lamivudine. A review of its therapeutic potential in chronic hepatitis B.

Authors:  B Jarvis; D Faulds
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.